A systematic review of the efficacy of aspirin monotherapy versus other antiplatelet therapy regimens in peripheral arterial disease
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Surgery
Reference55 articles.
1. Mortality over a period of 10 years in patients with peripheral arterial disease;Criqui;N Engl J Med,1992
2. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease;Bosch;Radiology,1997
3. Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis;Inoue;JACC Cardiovasc Interv,2011
4. Collaborative overview of randomised trials of antiplatelet therapy—I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists’ Collaboration;BMJ,1994
5. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?;Mohler;Catheter Cardiovasc Interv,2009
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Markers of Optimal Medical Therapy are Associated with Improved Limb Outcomes After Elective Revascularization for Intermittent Claudication;Journal of Vascular Surgery;2024-08
2. Optimal antiplatelet therapy after revascularization of left subclavian artery during TEVAR;Journal of Cardiothoracic Surgery;2024-06-28
3. Practice patterns of antiplatelet and anticoagulant therapy after fenestrated/branched endovascular aortic repair;Journal of Vascular Surgery;2024-05
4. Validation of the Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria in patients undergoing peripheral endovascular interventions;EuroIntervention;2023-04
5. Mono or Dual Antiplatelet Therapy for Treating Patients with Peripheral Artery Disease after Lower Extremity Revascularization: A Systematic Review and Meta-Analysis;Pharmaceuticals;2022-05-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3